2100 participants
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2025-12-19
- Completion:
- 2029-10-15
Conditions
- Coronary Artery Disease
Interventions
- DEVICE
No Results Yet